CURE SYNGAP1, a 501(c)(3) organization, is proud to announce the award of a $25,000 grant to Dr. Àlex Bayés Puig, Group ...

Cells shrink a major internal structure as they age. New research shows this downsizing is deliberate—and linked to longer ...

A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.

Miami, FL / Syndication Cloud / January 23, 2026 / Kure Care a division of Veracor Group LLC Key Takeaways Approximately 6.5 to 6.7 million people in the U.S. are affected by chronic wounds each year, ...

Although DNA is tightly packed and safeguarded within the cell nucleus, it remains continually at risk of damage from normal ...

Fusobacterium nucleatum can drive DNA damage, tumor growth and metastasis, with heightened effects in cells with BRCA1 gene mutations.

Although DNA is tightly packed and protected within the cell nucleus, it is constantly threatened by damage from normal ...

Although DNA is tightly packed and protected within the cell nucleus, it is constantly threatened by damage from normal ...

Market valued at $48.59B in 2024, projected 4.60% CAGR growth driven by membrane cell adoption, pulp paper demand, and ...

The company’s cross-disciplinary team lead by a Triple-Dr, Berenika Maciejewicz, applies bioengineering and AI towards human lifespan and healthspan extension.

Researchers have developed two innovative tools to help us delve deeper into cell communication, offering spatial insight ...